Blood-brain barrier disruption in CCL2 transgenic mice during pertussis toxin-induced brain inflammation. 2012

Angela E Schellenberg, and Richard Buist, and Marc R Del Bigio, and Henrik Toft-Hansen, and Reza Khorooshi, and Trevor Owens, and James Peeling
Department of Pharmacology & Therapeutics, University of Manitoba, 753 McDermot Avenue, Winnipeg, Manitoba, R3E 0T6, Canada. aes146@mail.usask.ca.

BACKGROUND The chemokine CCL2 has an important role in the recruitment of inflammatory cells into the central nervous system (CNS). A transgenic mouse model that overexpresses CCL2 in the CNS shows an accumulation of leukocytes within the perivascular space surrounding vessels, and which infiltrate into the brain parenchyma following the administration of pertussis toxin (PTx). METHODS This study used contrast-enhanced magnetic resonance imaging (MRI) to quantify the extent of blood-brain barrier (BBB) disruption in this model pre- and post-PTx administration compared to wild-type mice. Contrast-enhanced MR images were obtained before and 1, 3, and 5 days after PTx injection in each animal. After the final imaging session fluorescent dextran tracers were administered intravenously to each mouse and brains were examined histologically for cellular infiltrates, BBB leakage and tight junction protein. RESULTS BBB breakdown, defined as a disruption of both the endothelium and glia limitans, was found only in CCL2 transgenic mice following PTx administration and seen on MR images as focal areas of contrast enhancement and histologically as dextrans leaking from blood vessels. No evidence of disruption in endothelial tight junctions was observed. CONCLUSIONS Genetic and environmental stimuli were needed to disrupt the integrity of the BBB in this model of neuroinflammation.

UI MeSH Term Description Entries

Related Publications

Angela E Schellenberg, and Richard Buist, and Marc R Del Bigio, and Henrik Toft-Hansen, and Reza Khorooshi, and Trevor Owens, and James Peeling
October 2010, Neuroscience letters,
Angela E Schellenberg, and Richard Buist, and Marc R Del Bigio, and Henrik Toft-Hansen, and Reza Khorooshi, and Trevor Owens, and James Peeling
August 2015, Epilepsy & behavior : E&B,
Angela E Schellenberg, and Richard Buist, and Marc R Del Bigio, and Henrik Toft-Hansen, and Reza Khorooshi, and Trevor Owens, and James Peeling
January 2018, Oncotarget,
Angela E Schellenberg, and Richard Buist, and Marc R Del Bigio, and Henrik Toft-Hansen, and Reza Khorooshi, and Trevor Owens, and James Peeling
February 2017, Ultrasound in medicine & biology,
Angela E Schellenberg, and Richard Buist, and Marc R Del Bigio, and Henrik Toft-Hansen, and Reza Khorooshi, and Trevor Owens, and James Peeling
March 2023, Journal of translational medicine,
Angela E Schellenberg, and Richard Buist, and Marc R Del Bigio, and Henrik Toft-Hansen, and Reza Khorooshi, and Trevor Owens, and James Peeling
November 2019, The Science of the total environment,
Angela E Schellenberg, and Richard Buist, and Marc R Del Bigio, and Henrik Toft-Hansen, and Reza Khorooshi, and Trevor Owens, and James Peeling
January 2021, CNS neuroscience & therapeutics,
Angela E Schellenberg, and Richard Buist, and Marc R Del Bigio, and Henrik Toft-Hansen, and Reza Khorooshi, and Trevor Owens, and James Peeling
May 2005, International journal of radiation oncology, biology, physics,
Angela E Schellenberg, and Richard Buist, and Marc R Del Bigio, and Henrik Toft-Hansen, and Reza Khorooshi, and Trevor Owens, and James Peeling
January 2016, Brain, behavior, and immunity,
Angela E Schellenberg, and Richard Buist, and Marc R Del Bigio, and Henrik Toft-Hansen, and Reza Khorooshi, and Trevor Owens, and James Peeling
May 2024, Cells,
Copied contents to your clipboard!